Sanofi Credit Rating

결과 1 - 50 의 78

페이지 의 2 Next

__필터 기준:

일자	문서 유형	제목	자료출처
14 Dec 2020	Credit Opinion	Sanofi: Update following publication of Q3 results	Moody's Investors Service
19 Aug 2020	이슈어 커멘트	Sanofi: Financial flexibility for mid-sized acquisitions remains after tender offer on Principia	Moody's Investors Service
11 Aug 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Sanofi	Moody's Investors Service
03 Jun 2020	Credit Opinion	Sanofi: Update following rating affirmation	Moody's Investors Service
02 Jun 2020	Rating Action	Moody's affirms Sanofi's A1 ratings following the sale of its stake in Regeneron	Moody's Investors Service
20 May 2020	Credit Opinion	Sanofi: Update to credit analysis following Q1 2020 results	Moody's Investors Service
29 Nov 2019	Credit Opinion	Sanofi: Update to credit analysis	Moody's Investors Service
24 Sep 2019	보도자료	Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023	Moody's Investors Service
24 Sep 2019	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Sanofi	Moody's Investors Service
28 May 2019	Credit Opinion	Sanofi: Update to credit analysis	Moody's Investors Service
31 Oct 2018	보도자료	Moody's: French corporate bond issuance to remain steady in the next 18 months; credit quality stable	Moody's Investors Service
17 Sep 2018	Peer Snapshot	Sanofi - June 2018 (LTM): Peer Snapshot	Moody's Investors Service
30 May 2018	Credit Opinion	Sanofi: Update to discussion of key credit factors	Moody's Investors Service
27 Apr 2018	이슈어 커멘트	Sanofi: New share buyback program will slightly delay the recovery of credit metrics	Moody's Investors Service
19 Apr 2018	이슈어 커멘트	Sanofi: Sanofi’s disposal of European generics business Zentiva is credit positive	Moody's Investors Service
11 Apr 2018	Peer Snapshot	Sanofi - December 2017 (LTM): Peer Snapshot	Moody's Investors Service
12 Feb 2018	보도자료	Moody's: M&A greatest downside risk to European pharma companies' credit quality in 2018	Moody's Investors Service
01 Feb 2018	이슈어 커멘트	Sanofi: Sanofi’s acquisition of Ablynx increases financial leverage	Moody's Investors Service
30 Jan 2018	이슈어 커멘트	Sanofi: Sanofi’s €3.9 billion acquisition of Ablynx stretches financial flexibility	Moody's Investors Service
24 Jan 2018	Rating Action	Moody's affirms Sanofi's A1 ratings following Bioverativ acquisition	Moody's Investors Service
19 Oct 2017	보도자료	Moody's: Low rates and improving economy to keep French companies' debt issuance steady in 2018	Moody's Investors Service
06 Sep 2017	Peer Snapshot	Sanofi - June 2017 (LTM): Peer Snapshot	Moody's Investors Service
13 Jul 2017	Issuer In-Depth	Sanofi: Scenario analysis - a notional $10 billion acquisition unlikely to change A1 rating, but a larger debt-funded deal might	Moody's Investors Service
20 Jun 2017	Credit Opinion	Sanofi: Update to discussion of key credit factors	Moody's Investors Service
04 Apr 2017	Peer Snapshot	Sanofi - December 2016 (LTM): Peer Snapshot	Moody's Investors Service
30 Mar 2017	이슈어 커멘트	Sanofi: FDA Approval of Dupixent Is Credit Positive for Sanofi	Moody's Investors Service
10 Feb 2017	보도자료	Moody's: Pipelines are biggest credit quality hope for Europe's Pharma sector in 2017	Moody's Investors Service
17 Oct 2016	보도자료	Moody's : Résilience des volumes d'émission obligataires, entretenue par les grands émetteurs récurrents, en France en 2017	Moody's Investors Service
31 Aug 2016	Peer Snapshot	Sanofi: Peer Snapshot	Moody's Investors Service
27 Jun 2016	Credit Opinion	Sanofi S.A.: Update to Discussion of Key Credit Factors	Moody's Investors Service
02 May 2016	이슈어 커멘트	Sanofi's Offer to Acquire Medivation in All-Cash Deal Is Credit Negative	Moody's Investors Service
29 Apr 2016	이슈어 커멘트	Sanofi: Sanofi's proposed acquisition of Medivation can be accomodated under current rating	Moody's Investors Service
11 Mar 2016	이슈어 커멘트	Sanofi SA: Phase 3 results of sarilumab show stronger efficacy than adalimumab; a credit positive	Moody's Investors Service
10 Feb 2016	보도자료	Moody's: Europe's pharma companies' earnings growth looking less rosy in 2016	Moody's Investors Service
17 Dec 2015	이슈어 커멘트	Sanofi's Asset Swap with Boehringer Ingelheim Would Be Credit Positive	Moody's Investors Service
15 Dec 2015	이슈어 커멘트	Sanofi SA: Sanofi enters exclusive negotiations with Boheringer Ingelheim on asset swap, a credit positive	Moody's Investors Service
11 Aug 2015	보도자료	Moody's: Accelerated growth expected for EMEA Pharmaceuticals in 2016	Moody's Investors Service
03 Jul 2015	Credit Opinion	Sanofi	Moody's Investors Service
08 Apr 2015	이슈어 커멘트	Sanofi: Peer Snapshot	Moody's Investors Service
11 Feb 2015	보도자료	Moodys: Low growth rates expected for 2015 EMEA Pharma companies	Moody's Investors Service
23 May 2014	Speical Comment	Global Pharmaceuticals: European Pharma Roundtable Q&A Highlights	Moody's Investors Service
28 Mar 2013	Rating Action	Moody's upgrades Sanofi to A1; stable outlook	Moody's Investors Service
31 Jan 2013	크레딧 포커스	Sanofi: Diversification Drive and Emerging Market Expansion Dilute Effects From Patent Expiries and Pricing Pressures	Moody's Investors Service
23 May 2012	보도자료	Moody's changes outlook on Sanofi's A2 rating to positive from stable	Moody's Investors Service
05 Apr 2012	보도자료	Moody's Disclosures on Credit Ratings of Sanofi	Moody's Investors Service
14 Mar 2012	Speical Comment	European Pharmaceutical Companies: Resumption of Share Buybacks Could Weigh on Certain Ratings	Moody's Investors Service
23 Sep 2011	Analysis	GlaxoSmithKline vs. Sanofi: A Comparison of Two European Pharmaceutical Companies	Moody's Investors Service
21 Jun 2011	Rating Action	Moody's upgrades Genzyme to A2; stable outlook	Moody's Investors Service
26 May 2011	보도자료	Moody's continues review of Genzyme's Baa2 ratings	Moody's Investors Service
18 Feb 2011	Rating Action	Moody's downgrades sanofi-aventis to A2; confirms P-1 rating; outlook stable	Moody's Investors Service

결과 1 - 50 의 78

페이지 의 2 Next

리서치 & 등급

상품 및 솔루션

뉴스 & 이벤트

로그인

회원가입?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: